Corrado Ficorella
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Diabetes Treatment and Management, Pancreatic and Hepatic Oncology Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable(2019)410 cited
- → Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice(2020)255 cited
- → Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study(2019)219 cited
- → Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis(2009)205 cited
- → Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients(2019)175 cited
- → Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients(2011)144 cited
- → Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer(2001)143 cited
- → Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma(2010)143 cited
- → Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer(2009)135 cited
- → Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy(2021)134 cited